Home » Newsletters » BioWorld Asia

BioWorld Asia

May 30, 2001

View Archived Issues

Neurotech Raises $30M Privately To Fund Work In Cell Therapies

Small RNA Chunks Can Silence Single Genes In Mammalian Cells

Biota Purchases U.S. Company With Antivirals Program For $8M

Nine German Proteome Projects Get Started Under New Program

UK Initiative Provides Hospitals Incentive For Research Spin-Offs

EU Members Falling Behind On Biotechnology Research Rules

Hybrigenics, Institut Curie Create Joint Cancer Research Facility

Transgene Financing Nets $54M; BioMérieux Stake Reaches 70%

Ceros Settles In UK To Work On Leptin, Bone Formation Link

Other News To Note

TVMs First Closing Of New Venture Fund Nets EUR70M

MS Drugs Spur 33 Percent Growth In Israeli Biotech

EMEA Establishes New Rules Covering Gene Transfer Testing

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...